The power of sugar chains can be harnessed to develop new cancer immunotherapy by targeting specific glycan structures on cancer cells. Glycans play a role in immune evasion, and modifying them can enhance the immune recognition of cancer cells. Researchers aim to design therapies that leverage these sugar chains to stimulate the immune system effectively, promoting targeted and enhanced anti-cancer responses. This innovative approach holds promise for developing more precise and potent cancer immunotherapies.
